comparemela.com

Latest Breaking News On - Martin renner - Page 1 : comparemela.com

APONTIS PHARMA and Develco Pharma enter development partnership for launch of two Single Pills with pan-European intellectual property rights

05.05.2022 APONTIS PHARMA and Develco Pharma enter development partnership for launch of two Single Pills with pan-European intellectual property rights | APONTIS PHARMA AG | News | Nachricht | Mitteilung

Investegate |APONTIS PHARMA AG Announcements | APONTIS PHARMA AG: APONTIS PHARMA and Develco Pharma enter development partnership for launch of two Single Pills with pan-European intellectual property rights

Investegate announcements from APONTIS PHARMA AG, APONTIS PHARMA and Develco Pharma enter development partnership for launch of two Single Pills with pan-European intellectual property rights

HMNC Holding GmbH: HMNC Brain Health and Develco Pharma Announce Promising Preliminary Results in Treatment-Resistant Depression (TRD), suggesting antidepressant efficacy and showing Placebo-Level Dissociative Side Effects in Phase 2 oral prolonged-releas

Phase 2 Proof-of-Concept study in TRD patients resistant to standard antidepressants suggests positive trend in efficacy.Potential first-in-class oral prolonged-release formulation of ketamine, KET01,

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.